Evidence map›Paper›PMID 38966540›Full record

ArticleFrontiers in medicine2024

Development of the CDISC Pediatrics User Guide: a CDISC and conect4children collaboration.

John Owen, Anando Sen, Beate Aurich, Corinna Engel, Giacomo Cavallaro, Eva Degraeuwe, Dipak Kalra, Ronald Cornet, Melissa Walsh, Teresa Berkery and 11 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Paediatric-specific content in data standards for health.Archives of disease in childhood · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

John Owen *CDISC Europe Foundation, Brussels, Belgium.
Anando Sen *John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Beate AurichDrug Safety Consulting S.A.S.U., Paris, France.
Corinna EngelCenter for Pediatric Clinical Studies, University Children's Hospital Tübingen, Tuebingen, Germany.
Giacomo CavallaroNICU, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Eva DegraeuweDepartement of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Dipak KalraThe European Institute for Innovation through Health Data, Ghent, Belgium.
Ronald CornetDepartment of Medical Informatics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
Melissa WalshINFANT Research Centre, University College Cork, Cork, Ireland.
Teresa BerkeryINFANT Research Centre, University College Cork, Cork, Ireland.
Avril PalmeriJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Fenna MahlerDepartment of Pharmacy, Division Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, Netherlands.
Salma MalikThe European Clinical Research Infrastructure Network, Paris, France.
Laura PersijnDepartement of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Chima AmadiJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Jacques ThuetInstitut de Recherches Internationales Servier, Suresnes, France.
Simon WoodworthINFANT Research Centre, University College Cork, Cork, Ireland.
Sinead NallyNovartis Pharmaceuticals, Dublin, Ireland.
Rebecca LearyJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Richard MarshallCDISC Europe Foundation, Brussels, Belgium.
Volker StraubJohn Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The conect4children (c4c) project aims to facilitate efficient planning and delivery of paediatric clinical trials. One objective of c4c is data standardization and reuse. Interoperability and reusability of paediatric clinical trial data is challenging due to a lack of standardization. The Clinical Data Interchange Standards Consortium (CDISC) standards that are required or recommended for regulatory submissions in several countries lack paediatric specificity with limited awareness within academic institutions. To address this, c4c and CDISC collaborated to develop the Pediatrics User Guide (PUG) consisting of cross-cutting data items that are routinely collected in paediatric clinical trials, factoring in all paediatric age ranges. Methods and Results: The development of the PUG consisted of six stages. During the scoping phase, subtopics (each containing several clinically relevant concepts) were suggested and debated for inclusion in the PUG. Ninety concepts were selected for the modelling phase. Concept maps describing the Research Topic and representation procedure were developed for the 19 concepts that had no (or partial) previous modelling in CDISC. Next, metadata and implementation examples were developed for concepts. This was followed by a CDISC internal review and a public review. For both these review stages, the feedback comments were either implemented or rejected based on budget, timelines, expert review, and scope. The PUG was published on the CDISC website on February 23, 2023. Discussion: The PUG is a first step in bridging the lack of child specific CDISC standards, particularly within academia. Several academic and industrial partners were involved in the development of the PUG, and c4c has undertaken multiple steps to publicize the PUG within its academic partner organizations - in particular, the European Reference Networks (ERNs) that are developing registries and dictionaries in 24 disease areas. In the long term, continued use of the PUG in paediatric clinical trials will enable the pooling of data from multiple trials, which is particularly important for medical domains with small populations.

Indexed as

CDISCdata dictionarydata standardsinteroperabilitypaediatric clinical trials

Identifiers

PMID38966540
PMCPMC11222900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.